Navigation Links
Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia
Date:11/3/2008

s annual meeting and scientific exposition, in Philadelphia, Pennsylvania, USA on November 4-9, 2008. Dr. Michal Dranitzki Elhalel, principal nephrologist in the study will present on Thursday, November 6, 2008 at 4:45 p.m. at the Clinical Nephrology Conference and Medgenics Senior Scientists will present Medgenics' GMP vector and Toxicity Study in the Poster Session on Saturday, November 8, beginning at 10:00 am, at the Pennsylvania Convention Center.

Commenting on the preliminary results, Dr. Andrew Pearlman, Chief Executive Officer of Medgenics, said:

"While early data from the first two subjects is only a first indicator from this 30 subject study, we are encouraged that this study will show that Medgenics' EPODURE Biopump can be used to safely elevate hemoglobin levels in subjects with chronic kidney disease for three to six months (or more) from a single implant of one or more Biopumps. We look forward to reporting further as the study proceeds but, given the data collected and the apparent lack of an adverse immune response to the technology so far, we are cautiously optimistic that the trial will support the Directors' belief in this breakthrough platform technology."

For further information, contact:

Medgenics, Inc. Phone: +972 4 902 8900

Dr. Andrew L. Pearlman

Grayling Global (Financial PR, UK) Phone: +44 207 255 5406

Jonathan Shillington jonathan.shillington@uk.grayling.com

Alistair Scott

Blomfield Corporate Finance Limited Phone: +44 207 489 4500

(Nominated Adviser)

James Pinner

Alan MacKenzie

SVS Securities plc (Broker) Phone: +44 207 638 5600

Peter Manfield

Ian Callaway

United States contacts:

Grayling Global, Investor Relations Phone: +1 646 284 8472

Leslie Wolf-Creutzfeldt

SOURCE Medgenics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 PI’s ... wide and provide 15 mm travel range with ... The small dimensions make these new positioners the ... spaces. A vacuum rated version is also available. ... specifications and datasheets can be found at: , ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... May 23, 2013 Z Trim Holdings, Inc. ... to a variety of industries, announced that Chef ... discussion at this year,s National Restaurant Association ("NRA") NRA ... behalf of the Research Chefs Association.  Chef Ryan spoke ... Good, the Bad and the Ugly," joining four other ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... Inc. (NYSE: AOB ), a leading manufacturer and ... that it plans to release third quarter 2007 financial ... The company will hold a conference call on ... fiscal third quarter results. Listeners may access the,call by ...
... Kosan Biosciences,Inc. (Nasdaq: KOSN ) today ... Day on Wednesday, October 31, 2007, beginning at ... In addition to,presentations by Kosan,s Executives, Robert G. ... and Pieter Timmermans, Ph.D., Senior,Vice President, Drug Discovery ...
... Oct. 24 Codexis, Inc., a private,biotechnology company ... the opening of Codexis Laboratories Singapore,Pte. Ltd. (CLS). ... Asia, and,is an expansion of the company,s research ... will support the company,s pharmaceuticals business in,both the ...
Cached Biology Technology:American Oriental Bioengineering Announces Reporting Date for Third Quarter 2007 Financial Results 2Kosan Biosciences to Host Research & Development Day on October 31, 2007 2Kosan Biosciences to Host Research & Development Day on October 31, 2007 3Codexis Opens Singapore Laboratory 2
(Date:5/23/2013)... HOUSTON (May 23, 2013) A new report ... responsible for helping pupils engage in at least 60 ... school day. , No more than half of American ... hour of vigorous or moderate intensity physical activity daily, ... , "Because children are in school for nearly half ...
(Date:5/23/2013)... team reveal the interplay of brain chemicals which help ... Trust and BBSRC. , By changing the way ... abilities. While these changes can affect the strength of ... of that response. , Lead author Alex ... with others, you can make yourself better heard by ...
(Date:5/22/2013)... in fuel cell powered buses, including a team ... electrode degradation processes and bus membrane durability. , ... degradation stressors in the operating cycle of the ... of the study, led by SFU graduate student ... study at Burnaby-based Ballard Power Systems and funded ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2Tests lead to doubling of fuel cell life 2
... written by Rosa Binimelis, Walter Pengue and Iliana Monterroso, ... University of Barcelona, University of Buenos Aires and the ... The article describes the geographical advance of the invasion ... the invasion process to discuss the major drivers and ...
... Supply Chain Council (SCC) announced today it has joined ... offer a unique new program that will enhance the ... professionals.SCC is the world,s leading authority on supply chain ... while APICS is the leader in operations management and ...
... ALEXANDRIA, Va., May 7 Today, the White House ... funding for the Carl D. Perkins Career and Technical ... Act is the primary source of federal funding that ... careers. The Association for Career and Technical Education (ACTE) ...
Cached Biology News:Weed resistance to glyphosate in genetically modified soybean cultivation in Argentina 2Supply Chain Council Partners With APICS The Association for Operations Management 2Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3
Anti-human C5a/C5a des-Arg (neo-epitode), Clone 2952, Monoclonal Antibody...
Reacts with the 80 kDa fragment of the M-chain of human merosin....
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
... Rabbit polyclonal to ZFP91 ( ... Antigen: Synthetic ... 280 of human ZFP91. (Note: ... Entrez ...
Biology Products: